Acquisition of a CD19-negative myeloid phenotype allows immune escape of MLL-rearranged B-ALL from CD19 CAR-T-cell therapy
Rebecca Gardner(Seattle Children's Hospital), Cameron J. Turtle(The University of Sydney)
Cited by 743
Related Papers
Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults
|Blood|2017|1.1k
Kinetics and biomarkers of severe cytokine release syndrome after CD19 chimeric antigen receptor–modified T-cell therapy
|Blood|2017|1.1k
HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells
|Nature Biotechnology|2017|623